Executive Team

About MolecuLight Inc.

MolecuLight Inc. is a privately owned, Canadian medical imaging company founded by Dr. Ralph DaCosta and incorporated on June 1, 2012. The company’s first product, the MolecuLight i:X, is a first-of-its kind handheld imaging device based on Dr. DaCosta’s invention. MolecuLight is based in Toronto, Canada and has an exclusive global distributor partnership with Smith & Nephew.


Management Team

MolecuLight's management team has extensive experience working with development companies in the medical device, pharmaceutical, and wound care industries.

Board of Directors

MolecuLight is guided by a board of directors who have achieved success in various companies within the healthcare industry where they provided business perspectives and insights for the advancement of those companies.

MolecuLight Inc.'s Mission & Values

Mission Statement

MolecuLight’s mission is to become the ubiquitous name in fluorescence-guided imaging technologies to improve health outcomes for patients globally through innovative products and services that optimize the delivery of health care and become standard of care in wound care and breast cancer.


Quality Statement

We will develop, sell and deploy products and services that exceed customer expectations, while complying with regulatory standards. MolecuLight Inc. operates under the control of an ISO 13485:2016 Quality Management System.


Core Values

  • Operating in an ethical manner at all times
  • Improving patient outcomes through product innovation
  • Remaining focused on customer, employee, and shareholder needs
  • Working hard and taking pride in our accomplishments
  • Valuing the contributions of each and every team member